Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SL9A6 | Q92581 | Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Solute carrier family 9 member 6) | Disease related genesHuman disease related genesPotential drug targets | 12 | EpilepsyIntellectual disability | Clinical-translation mediationFusion and delivery mediation | 5 | 0.40 | ||
| TPOR | P40238 | Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110) | 1 | Acute myeloid leukaemiaIschaemic/haemorrhagic strokeLiver disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.40 | |||
| AT1B2 | P14415 | Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia) (AMOG) (Sodium/potassium-dependent ATPase subunit beta-2) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.40 | |||
| BKRB2 | P30411 | B2 bradykinin receptor (B2R) (BK-2 receptor) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaBrain cancerCerebral ischaemic stroke | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 4 | 0.40 | ||
| COPT2 | O15432 | Protein SLC31A2 (Copper transporter 2) (hCTR2) (Solute carrier family 31 member 2) | Predicted membrane proteinsTransporters | 3 | Fusion and delivery mediation | 4 | 0.40 | |||
| GTR2 | P11168 | Solute carrier family 2, facilitated glucose transporter member 2 (Glucose transporter type 2, liver) (GLUT-2) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 4 | 0.40 | |||
| MMP24 | Q9Y5R2 | Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] | EnzymesPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 4 | 0.40 | |||
| MOT8 | P36021 | Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter) | 12 | Fusion and delivery mediation | 4 | 0.40 | ||||
| MTLR | O43193 | Motilin receptor (G-protein coupled receptor 38) | 7 | Bowel habit changeDigestive system diseaseDyspepsia | Clinical-translation mediationReceptor-signaling mediation | 4 | 0.40 | |||
| NEP | P08473 | Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Charcot-Marie-Tooth diseaseSpinocerebellar ataxiaAsthma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.40 |